- 英文名称
- (+)-Cloprostenol sodium
- 分子式
- C22H28ClNaO6
- 分子量
- 446.9
- 中文别名
- (+)-氯前列醇钠; D-氯前列醇钠; 氯前列醇钠; (5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-氯苯氧基)-3-羟基-1-丁烯-1-基]-3,5-二羟基环戊基]-5-庚烯酸钠盐; D-氯前列醇钠盐; (Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-氯苯氧基)-3-羟基丁-1-烯-1-基)-3,5-二羟基环戊基)庚-5-烯酸钠; Cloprostenol sodium; Cloprostenol NA; Cloprostenol sodium salt; Sodium (Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate; sodium [1alpha(z),2beta(1e,3r*),3alpha,5alpha]-(+/-)-7-[2-[4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate; (+)-16-M-CHLOROPHENOXY TETRANOR PROSTAGLANDIN F2ALPHA SODIUM SALT; 16-(M-CHLOROPHENOXY)-TETRANOR-PROSTAGLANDIN-F2ALPHA, SODIUM SALT; 16-(3-CHLOROPHENOXY)-9,11,15R-TRIHYDROXY-17,18,19,20-TETRANORPROSTA-5Z,13E-DIEN-1-OIC ACID SODIUM SALT; (5Z)-REL-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-CHLOROPHENOXY)-3-HYDROXY-1-BUTENYL]-3,5-DIHYDROXYCYCLOPENTYL]-5-HEPTENOIC ACID MONOSODIUM SALT; (+)-9ALPHA,11ALPHA,15R-TRIHYDROXY-16-(3-CHLOROPHENOXY)-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID, SODIUM SALT; (±)-Sodium (Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(m-Chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate; Sodium (5Z)-7-{(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl}-5-heptenoate; (5Z)-rel-7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoic Acid Monosodium Salt; 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, sodium salt, (5Z)- (1:1)
- 用途
- 氯前列烯醇钠是无菌水溶液的钠盐，为白色或类白色结晶粉末，可用于化学试剂及科学领域研究，作为实验室研发和化工医药合成过程中的有机合成中间体和医药中间体，广泛应用于母猪同期发情、诱导发情、卵巢及子宫疾病的治疗等药物相关用途。
